Effects of SQ 14,225, an orally active inhibitor of angiotensin-converting enzyme on blood pressure, heart rate and plasma renin activity of conscious normotensive dogs
- 15 October 1978
- journal article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 51 (4), 345-349
- https://doi.org/10.1016/0014-2999(78)90426-0
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Design of potent competitive inhibitors of angiotensin-converting enzyme. Carboxyalkanoyl and mercaptoalkanoyl amino acidsBiochemistry, 1977
- Inhibition of angiotensin converting enzyme by SQ 14,225 in conscious rabbitsEuropean Journal of Pharmacology, 1977
- Design of Specific Inhibitors of Angiotensin-Converting Enzyme: New Class of Orally Active Antihypertensive AgentsScience, 1977
- A SPECIFIC ORALLY ACTIVE INHIBITOR OF ANGIOTENSIN-CONVERTING ENZYME IN MANThe Lancet, 1977
- Possible Role of Renin in Hypertension as Suggested by Renin-Sodium Profiling and Inhibition of Converting EnzymeNew England Journal of Medicine, 1977
- Conversion of angiotensin I to angiotensin IIAmerican Journal Of Medicine, 1976
- Mechanisms regulating renin releasePhysiological Reviews, 1976
- PLASMA RENIN ACTIVITY OF RATS AND RABBITS IMMUNIZED AGAINST ANGIOTENSIN IIClinical and Experimental Pharmacology and Physiology, 1974
- Inhibition by SQ 20881 of vasopressor response to angiotensin I in conscious animalsEuropean Journal of Pharmacology, 1973
- Inhibition of Angiotensin Conversion in Experimental Renovascular HypertensionScience, 1972